HNB
ALT icon

Huntington National Bank’s Altimmune ALT Stock Holding History

Huntington National Bank’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6 Hold
2
– – ﹤0.01% 3871
2025
Q4 		$7 Hold
2
– – ﹤0.01% 3758
2025
Q3 		$8 Hold
2
– – ﹤0.01% 3760
2025
Q2 		$8 Hold
2
– – ﹤0.01% 3758
2025
Q1 		$10 Hold
2
– – ﹤0.01% 3726
2024
Q4 		$14 Hold
2
– – ﹤0.01% 3622
2024
Q3 		$12 Hold
2
– – ﹤0.01% 3670
2024
Q2 		$13 Hold
2
– – ﹤0.01% 3591
2024
Q1 		$20 Hold
2
– – ﹤0.01% 3296
2023
Q4 		$23 Hold
2
– – ﹤0.01% 3128
2023
Q3 		$5 Sell
2
-1,838
-100% -$5.27K ﹤0.01% 3569
2023
Q2 		$6.5K Buy
1,840
+1,838
+91,900% +$8.25K ﹤0.01% 1710
2023
Q1 		$8 Hold
2
– – ﹤0.01% 3294
2022
Q4 		$33 Hold
2
– – ﹤0.01% 2586
2022
Q3 		$0 Hold
2
– – ﹤0.01% 1985
2022
Q2 		$0 Hold
2
– – ﹤0.01% 2015
2022
Q1 		$0 Hold
2
– – ﹤0.01% 2027
2021
Q4 		$0 Sell
2
-504
-100% -$5.36K ﹤0.01% 2004
2021
Q3 		$6K Buy
506
+172
+51% +$2.09K ﹤0.01% 1539
2021
Q2 		$3K Buy
+334
New +$4.57K ﹤0.01% 1609

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Huntington National Bank's ALT Position: Q1 2026 in Review

Huntington National Bank held its Altimmune (ALT) position steady in Q1 2026 at 2 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #3871.

Huntington National Bank first reported a position in ALT in Q2 2021 and has held it in 20 quarters since. The position peaked at $6.5K in Q2 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Huntington National Bank held 2 shares of Altimmune worth $6 as of Q1 2026.
  • Huntington National Bank left its Altimmune share count unchanged in Q1 2026.
  • Altimmune made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3871 holding.
  • Huntington National Bank first reported a position in Altimmune in Q2 2021 and has held it in 20 quarters since.
  • Huntington National Bank's Altimmune position peaked at $6.5K in Q2 2023.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.